“In Silico Study on 5-hydroxy-2-(4-hydroxyphenyl)-6,7- dimethoxychromen-4-one as a Candidate IL-1R and TNF-R Inhibitor”, JOMALISC, vol. 3, no. 2, pp. 37–44, Nov. 2024, doi: 10.11113/jomalisc.v3.79.